Parkinsonism as a late presentation of lymphomatosis cerebri following high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma
暂无分享,去创建一个
[1] T. Greiner,et al. Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential , 2019, Insights into Imaging.
[2] R. Nitrini,et al. Diffuse large B-cell lymphoma of the central nervous system presenting as “lymphomatosis cerebri” and dementia in elderly man , 2019, Medicine.
[3] Y. Li,et al. Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson’s disease , 2018, International journal of molecular medicine.
[4] C. Zhong,et al. Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease. , 2019, Parkinsonism & related disorders.
[5] Dennis W Dickson,et al. Neuropathology of Parkinson disease. , 2018, Parkinsonism & related disorders.
[6] W. Poewe,et al. Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis , 2017, PloS one.
[7] M. Shiroishi,et al. Lymphomatosis cerebri: a rare variant of primary central nervous system lymphoma and MR imaging features , 2017, Cancer Imaging.
[8] A. Dagher,et al. Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression , 2017, Brain : a journal of neurology.
[9] M. Pfreundschuh,et al. High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group , 2017, Leukemia.
[10] J. Carnevale,et al. The Challenge of Primary Central Nervous System Lymphoma. , 2016, Hematology/oncology clinics of North America.
[11] A. Ferreri,et al. The role of autologous stem cell transplantation in primary central nervous system lymphoma. , 2016, Blood.
[12] Amos D. Korczyn,et al. Vascular parkinsonism—characteristics, pathogenesis and treatment , 2015, Nature Reviews Neurology.
[13] J. Finke,et al. Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] Rakesh Kumar,et al. Primary central nervous system lymphoma with lymphomatosis cerebri in an immunocompetent child: MRI and 18F-FDG PET-CT findings. , 2013, Revista espanola de medicina nuclear e imagen molecular.
[15] J. Finke,et al. Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] A. Spence,et al. Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man , 2006, Journal of Neuro-Oncology.
[17] J. Mazziotta,et al. Lymphomatosis cerebri Presenting as a Rapidly Progressive Dementia: Clinical, Neuroimaging and Pathologic Findings , 1999, Dementia and Geriatric Cognitive Disorders.